EFFECTS OF GEMIGLIPTIN VERSUS SITAGLIPTIN OR GLIMEPIRIDE ON GLYCEMIC VARIABILITY AS INITIAL COMBINATION THERAPY WITH METFORMIN IN DRUG-NAIVE PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Park, S. E. [1 ]
Lee, B. -W. [2 ]
Kim, J. H. [3 ]
Jung, C. H. [4 ]
Lee, S. -H. [5 ]
Suh, S. H. [3 ]
Lee, W. J. [4 ]
Jang, Y. H. [6 ]
Kim, S. -H. [6 ]
Park, C. -Y. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Severance Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[5] Catholic Univ Korea, Sch Med, Seoul St Marys Hosp, Seoul, South Korea
[6] LG Life Sci, Seoul, South Korea
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70474-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO180
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 50 条
  • [1] Effects of gemigliptin versus sitagliptin or glimepiride on glycaemic variability as initial combination therapy with metformin in drug-naive patients with type 2 diabetes
    Lee, B. -W.
    Kim, J.
    Park, S.
    Jung, C.
    Lee, S. -H.
    Suh, S.
    Lee, W.
    Cho, J. -H.
    Jang, Y.
    Kim, S. -H.
    Park, C. -Y.
    DIABETOLOGIA, 2015, 58 : S387 - S387
  • [2] Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes
    Lim, S.
    Min, K.
    Yu, J. -M.
    Chamnan, P.
    Kim, E.
    Yoon, K. -H.
    Kwon, S.
    Moon, M.
    Lee, K.
    Kim, D. -J.
    Kim, M.
    Wongtanate, M.
    Kim, E.
    Kim, S. -H.
    Lee, M. -K.
    DIABETOLOGIA, 2015, 58 : S54 - S54
  • [3] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [4] Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes
    Kim, Kyoung Min
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Dong Hwa
    Oh, Tae Jung
    Jang, Hak Chul
    Lim, Soo
    DIABETES, 2017, 66 : A346 - A346
  • [5] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Liu, G.
    Lee, M. A.
    Sisk, C. McCrary
    Williams-Herman, D. E.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETOLOGIA, 2010, 53
  • [6] Initial Combination Therapy with Metformin Plus Colesevelam in Drug-Naive Hispanic Patients with Early Type 2 Diabetes
    Rosenstock, Julio
    Hernandez-Triana, Eric
    Handelsman, Yehuda
    Misir, Soamnauth
    Jones, Michael R.
    Nagendran, Sukumar
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 7 - 13
  • [7] Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naive patients with type 2 diabetes: initial triple study
    Lim, Soo
    Ku, Eu Jeong
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Jie-Eun
    Kim, Kyoung Min
    Davies, Melanie J.
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [8] Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naive Type 2 Diabetes
    Rosenstock, Julio
    Chuck, Leonard
    Gonzalez-Ortiz, Manuel
    Merton, Kate
    Craig, Jagriti
    Capuano, George
    Qiu, Rong
    DIABETES CARE, 2016, 39 (03) : 353 - 362
  • [9] Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naive Patients With Type 2 Diabetes
    Rosenstock, Julio
    Inzucchi, Silvio E.
    Seufert, Jochen
    Fleck, Penny R.
    Wilson, Craig A.
    Mekki, Qais
    DIABETES CARE, 2010, 33 (11) : 2406 - 2408
  • [10] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Lee, M. A.
    Sisk, C. M.
    Williams-Herman, D. E.
    Engel, S. S.
    Kaufman, K. D.
    Goldstein, B. J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (09) : 930 - 938
12345